Cartalax

Description

Cartalax

Also known as: Ala-Glu-Asp, AED Tripeptide

Cartalax is a tissue-specific peptide bioregulator sourced from cartilage, investigated for its potential to support cartilage integrity, joint function, connective tissue health, and aspects of healthy aging. As part of a class of short peptide compounds designed to provide targeted cellular support, it is frequently studied in the contexts of musculoskeletal health, regenerative biology, and longevity science.

Primary areas of research and interest include:
– Supporting cartilage and joint health
– Maintaining connective tissue structure
– Applications in healthy aging protocols
– Promoting musculoskeletal well-being
– Studies on cellular regeneration and bioregulation

• Status: Approved for use in Russia – Not approved by the FDA. Evidence based on animal studies.
• Standard dosage: Community data is scarce; refer to established research protocols. Administered orally.
• Investigated uses: Supporting joint health and cartilage, as well as managing osteoarthritis.